Click Here for 5% Off Your First Aladdin Purchase!

miricorilant , CAS No.M611890, Antagonist of Glucocorticoid receptor

  • Moligand™
Item Number
M611890
Grouped product items
SKUSizeAvailabilityPrice Qty
M611890-5mg
5mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$1,300.90
M611890-25mg
25mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$2,000.90

Basic Description

SynonymsMiricorilant|CORT118335|Miricorilant [INN]|Miricorilant [USAN]|CORT-118335|311Y5GV21M|Miricorilant [USAN:INN]|UNII-311Y5GV21M|1400902-13-7|CHEMBL2204043|WHO 10853|6-(trans-4-Phenylcyclohexyl)-5-((3-(trifluoromethyl)phenyl)methyl)-2,4(1H,3H)-pyrimidinedion
GradeMoligand™
Action TypeANTAGONIST
Mechanism of actionAntagonist of Glucocorticoid receptor

Associated Targets

NR3C1 Tclin Glucocorticoid receptor 1 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

Names and Identifiers

IUPAC Name 6-(trans-4-phenylcyclohexyl)-5-{[3-(trifluoromethyl)phenyl]methyl}pyrimidine-2,4(1H,3H)-dione
INCHI InChI=1S/C24H23F3N2O2/c25-24(26,27)19-8-4-5-15(13-19)14-20-21(28-23(31)29-22(20)30)18-11-9-17(10-12-18)16-6-2-1-3-7-16/h1-8,13,17-18H,9-12,14H2,(H2,28,29,30,31)/t17-,18-
InChi Key GVVUZBSCYAVFTI-IYARVYRRSA-N
Canonical SMILES O=c1[nH]c(=O)c(c([nH]1)[C@@H]1CC[C@H](CC1)c1ccccc1)Cc1cccc(c1)C(F)(F)F
Isomeric SMILES C1CC(CCC1C2=CC=CC=C2)C3=C(C(=O)NC(=O)N3)CC4=CC(=CC=C4)C(F)(F)F
PubChem CID 66550324

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

Related Documents

References

1. Gross C, Blasey CM, Roe RL, Belanoff JK.  (2010)  Mifepristone reduces weight gain and improves metabolic abnormalities associated with risperidone treatment in normal men..  Obesity (Silver Spring),  18  (12): (2295-300).  [PMID:20339369]
2. Hunt HJ, Ray NC, Hynd G, Sutton J, Sajad M, O'Connor E, Ahmed S, Lockey P, Daly S, Buckley G et al..  (2012)  Discovery of a novel non-steroidal GR antagonist with in vivo efficacy in the olanzapine-induced weight gain model in the rat..  Bioorg Med Chem Lett,  22  (24): (7376-80).  [PMID:23131342]

Solution Calculators